Cindy K Miranti (C K Miranti)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Transforming Growth Factor

Radical Prostatectomy

Top Venues

The Journal of cell biology

Journal of cell science

This page only lists publications with an associated author ORCID identifier.

Publications

Shekha Tahsin, Neha S Sane, Brent Cernyar, Linan Jiang, Yitshak Zohar, Benjamin R Lee, Cindy K Miranti
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. Oncogene (2024)
Shekha Tahsin, Neha S Sane, Brent Cernyar, Linan Jiang, Yitshak Zohar, Benjamin R Lee, Cindy K Miranti
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. Oncogene 43 (27) (2024)
Shekha Tahsin, Neha S Sane, Brent Cernyar, Linan Jiang, Yitshak Zohar, Benjamin R Lee, Cindy K Miranti
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. Oncogene 43 (27) (2024)
Andrew W Hahn, Bilal A Siddiqui, Javier Leo, Eleonora Dondossola, Kaitlin J Basham, Cindy K Miranti, Daniel E Frigo
Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer. Endocrinology (2023)
Corbin C Jensen, Amber N Clements, Hope Liou, Lauren E Ball, Jennifer R Bethard, Paul R Langlais, Rachel K Toth, Shailender S Chauhan, Andrea L Casillas, Sohail R Daulat, Andrew S Kraft, Anne E Cress, Cindy K Miranti, Ghassan Mouneimne, Gregory C Rogers, Noel A Warfel
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of cell biology 222 (6) (2023)
McLane J Watson, P L Berger, K Banerjee, S B Frank, L Tang, S S Ganguly, G Hostetter, M Winn, Cindy K Miranti
Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation. Oncogene 40 (18) (2021)
Eric A Nollet, Marina Cardo-Vila, Sourik S Ganguly, Jack D Tran, Veronique V Schulz, Anne Cress, Eva Corey, Cindy K Miranti
Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene 39 (31) (2020)
Sourik S Ganguly, Galen Hostetter, Lin Tang, Sander B Frank, Kathylynn Saboda, Rohit Mehra, Lisha Wang, Xiaohong Li, Evan T Keller, Cindy K Miranti
Notch3 promotes prostate cancer-induced bone lesion development via MMP-3. Oncogene 39 (1) (2019)
Sander B Frank, Penny L Berger, Mats Ljungman, Cindy K Miranti
Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC. Journal of cell science 130 (11) (2017)